FDW
AZN icon

Fourth Dimension Wealth’s AstraZeneca AZN Stock Holding History

Fourth Dimension Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Buy
143
+45
+46% +$8.46K 0.01% 347
2026
Q1 		$19.3K Sell
98
-2
-2% -$386 0.01% 326
2025
Q4 		$18.4K Hold
100
– – 0.01% 344
2025
Q3 		$15.3K Hold
100
– – 0.01% 363
2025
Q2 		$14K Buy
100
+50
+100% +$7.01K 0.01% 373
2025
Q1 		$7.35K Hold
50
– – ﹤0.01% 454
2024
Q4 		$6.55K Buy
+50
New +$7K ﹤0.01% 477

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fourth Dimension Wealth's AZN Position: Q2 2026 in Review

Fourth Dimension Wealth increased its AstraZeneca (AZN) stake by 46% in Q2 2026, buying an estimated $8.46K and bringing the position to 143 shares worth $27.1K. The position accounts for 0.01% of the portfolio, ranked #347.

Fourth Dimension Wealth first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Fourth Dimension Wealth held 143 shares of AstraZeneca worth $27.1K as of Q2 2026.
  • Fourth Dimension Wealth bought 45 AstraZeneca shares in Q2 2026, an estimated $8.46K.
  • AstraZeneca made up 0.01% of Fourth Dimension Wealth's portfolio in Q2 2026, its #347 holding.
  • Fourth Dimension Wealth first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Fourth Dimension Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.